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ABSTRACT
Streptococcus intermedius, a member of the Streptococcus anginosus group and a part of the human oropharyngeal microbiome, is a 
recognised pathogen, mostly in immunocompromised patients or post gastrointestinal surgery, known to cause suppurative metastatic 
abscesses. We present an unusual case of bilateral empyema with pericardial effusion caused by Streptococcus intermedius in a 
healthy 30-year-old adult male patient with no known predisposing factors.This case report illustrates the ability of S. intermedius to 
produce life-threatening empyema in a healthy adult without any predisposing factors.
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Streptococcus anginosus group (SAG), which were previously called as “Streptococcus milleri group” up to 1996, consists of three distinct species, S. anginosus, S. 
constellatus, and S. intermedius. These organisms are part of the 
human oropharyngeal commensal flora and may be isolated from 
the throat, the nasopharynx, and the gingival crevices. They are 
known for their tendency to cause intra-abdominal infections 
(liver abscesses), intracranial and intraspinal abscesses, and 
in septic lesions of these and other internal organs [1]. In rare 
cases, it may cause meningitis [2], arthritis [3], endocarditis [4], 
purulent pericarditis [5] and primary purulent mediastinitis [6]. 
If bacteremia occurs, it is usually due to a focus of 
infection within the gastrointestinal and upper respiratory 
tract. Pulmonary infections can result from aspiration of 
oropharyngeal contents, leading to pneumonia, which may be 
complicated by empyema and lung abscesses. Anginosus group 
bacteria have also been isolated from sputum specimens of 
cystic fibrosis patients in association with disease exacerbations 
and clinical deterioration [7].
Virulence factors of the Streptococcus anginosus group are 
diverse, viz., presence of capsule on some strains, production of 
a partially characterised immunosuppressive protein, hydrolytic 
and glycosaminoglycan degrading enzymes, like Neuraminidase, 
DNAse, Chondroitin sulphate depolymerase and Hyaluronidase, 
inhibition of polymorphonuclear leukocyte chemotaxis and 
Staphylococcal leucocidin-like toxin called Intermedilysin 
(produced by Streptococcus intermedius). This report describes 
a case of bilateral empyema with pericardial effusion caused by 
Streptococcus intermedius.
CASE REPORT
A 30-year-old male patient, resident of New Delhi, India, with no 
known comorbidities or history of immunosuppression, presented 
to the Emergency of our hospital with acute shortness of breath. 
He complained of fever for the last 7 days, associated with 
shortness of breath, chest pain worsening on deep inspiration and 
non-productive cough. There was no significant family history. 
At the Emergency, the patient was found to have a toxic 
appearance with evident signs of dehydration. Examination 
of the respiratory system revealed bilateral diminished breath 
sounds and dullness on percussion. In view of low arterial 
oxygen saturation, as depicted in Arterial Blood Gas (ABG) 
analysis and hypotension, the patient was put on non-invasive 
ventilator support using BiPaP and the intravenous fluid 
replacement was started. 
Chest X-ray done on admission showed enlarged cardiac 
silhouette with bilateral pleural effusion (right more than left). 
Evidence of an air-fluid level was noted in the left paravertebral 
region in the upper and middle zone. The medial part of the cavity 
noted in the retro-aortic area. The lower margin of the cavity was 
indistinct (Fig. 1). High resolution Computed Tomography (CT) 
of chest corroborated with the chest x-ray findings, with evidence 
of pericardial effusion and the left-sided gross pleural thickening 
(Fig. 2). However, pneumonitis and esophageal perforation were 
ruled out (the most common source of Streptococcus anginosus 
group in case of primary purulent mediastinitis).
Bilateral intercostal drainage was put, and purulent fluid was 
obtained which was sent for microscopic and microbiological 
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evaluation. The patient was started empirically on Pipericillin 
and Tazobactum 4.5 grams intravenous (IV) three times daily, 
Clindamycin 600 milligrams IV twice daily and Teicoplanin 400 
milligrams IV twice daily for 1 day, followed by 400 mg once 
daily. Routine investigations revealed raised C - reactive protein, 
leucocytosis with neutrophilia and raised renal parameters. 
Microscopic evaluation of pleural fluid showed the accumulation 
of polymorphonuclear cells and debris. Pleural fluid was negative 
for Acid Fast Bacilli by Zeihl Neelsen staining and GeneXpert 
was also negative. Streptococcus intermedius was isolated as pure 
culture in blood agar (α-hemolytic colonies) from pleural fluid. 
Streptococcus intermedius was identified by Matrix-assisted Laser 
Desorption Ionization-Time of Flight Mass Spectroscopy and 
was corroborated with phenotypic biochemical properties, which 
placed the organism in Streptococcus anginosus group (Table 1).
Antibiotic susceptibility was done using the disc diffusion 
method as per Clinical and Laboratory Standards Institute 
guidelines. The isolate was found to be susceptible to 
Clindamycin, Cefotaxime, Erythromycin, Penicillin, Vancomycin 
and Linezolid. A pericardial drain was put, but the pericardial 
fluid obtained showed no growth. The patient was continued on 
Clindamycin for 10 days as per susceptibility reports. 
After 3 days of antibiotic therapy, the patient showed 
significant clinical improvement, which reflected in his 
laboratory parameters and was corroborated radiologically 
(Fig. 3). Intercostal drainage was omitted on day 4 after 
admission. The patient was weaned off non-invasive ventilator 
support as he started maintaining satisfactory oxygen 
saturation by day 3 after admission. The patient showed 
steady improvement with resolution of acute renal failure and 
other abnormal blood parameters and was finally discharged 
in hemodynamically and clinically stable condition on day 9 
after admission. There was no further deterioration or new 
clinical symptom on follow-up.
Figure 1: Chest X-Ray showing enlarged cardiac silhouette with 
bilateral pleural effusion (right more than left) and evidence of an air 
fluid level in the left paravertebral region in upper and middle zone.
Figure 2: High resolution CT scan of chest showingevidence of 
pericardial effusion and left sided gross pleural thickening.
Figure 3: Significant improvement radiologically, which reflected in 
his clinical condition also.
Biochemical test Result
Catalase Negative
Hemolysis on Sheep blood agar Alpha-hemolysis
Bacitracin Resistant
Sulphamethoxazole – trimethoprim Susceptible
Optochin Resistant
CAMP test Negative
6.5% NaCl No growth
Bile aesculin agar No growth
Arginine dihydrolase Positive
Aesculin hydrolysis Positive
Voges Proskauer Positive
Mannitol fermentation Negative
Raffinose Negative
Sorbitol Negative
Starch Negative
Urease Negative
Table 1: Results of biochemical investigations of the patient.
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DISCUSSION
Pulmonary infections caused by Streptococcus anginosus group 
are commonly secondary to aspiration of esophageal contents 
or a sequalae of esophageal perforation, in cystic fibrosis or 
immunosuppressed patients. Though pleural empyema caused 
by Streptococcus intermedius has been reported in the literature 
previously [8,9], no report of bilateral empyema with pericardial 
effusion in an immunocompetent adult could be found.
A study done in Vellore, a region in southern India showed 
a high incidence of severe human infections with β-hemolytic 
group C and G streptococci. Causative species in these infections 
were identified by 16S rRNA gene sequencing. Streptococcus 
dysgalactiae subsp. equisimilis (81%) and S. anginosus (19%) 
were the causative organisms in the 2-year study period 
(2006–2007) [10]. In another study on clinical and molecular 
epidemiology of beta-hemolytic streptococcal infections in 
India, done at AIIMS, New Delhi, Group A Streptococcus 
was the most common β-Haemolytic Streptococcus (71.5%), 
followed by Group G Streptococcus (21%). Among the Group 
G Streptococcus, 67% were identified as S. dysgalactiae, 15% 
as S. anginosus, 10% as S. dysgalactiae subsp. Equisimilis, 
and one isolate each as S. porcinus, S. alactolyticus, and S. 
mitis [11]. 
In one of the studies on Streptococcus milleri group 
(Earlier name of Streptococcus anginosus group), Penicillin 
G was the most active of the β-lactam antibiotics tested. As 
alternative antibiotics in the case of penicillin-allergic patients, 
erythromycin and clindamycin showed good activity. A high 
frequency of resistance to tetracycline was demonstrated. All 
the strains were sensitive to trimethoprim, vancomycin, and 
chloramphenicol [12]. 
In another study on 423 clinical “Streptococcus milleri” 
isolates, only 1.4% of the strains were of intermediate 
susceptibility to penicillin. None of the strains exhibited high-
level resistance to gentamicin. Strains resistant to erythromycin, 
roxithromycin and clindamycin were found with a frequency of 
2.6%, 2.4% and 2.4% respectively. All the strains were susceptible 
to cefotaxime, vancomycin and teicoplanin [13]. Some authors 
have expressed concern that clindamycin resistance in the S. 
milleri group is increasing [12,13]. However, our isolate was 
found to be susceptible to Clindamycin, as well as to Cefotaxime, 
Erythromycin, Penicillin, Vancomycin and Linezolid.
The mechanism of dissemination of S. intermedius to the 
patient’s pleural space, in absence of any predisposing factor, 
is unclear. It is possible that transient bacteremia from an oral 
or gastrointestinal source may have led to seeding of the pleural 
space. It is also possible that this particular S. intermedius 
isolate may have undergone some known Streptococcus 
genomic evolution pathway such as horizontal gene transfer 
as a mechanism of virulence factor acquisition resulting in an 
unusually hypervirulent S. intermedius strain [14].
CONCLUSION
This case report illustrates the ability of S. intermedius to 
produce life-threatening empyema in a healthy adult without 
any predisposing factors. This raises the question whether 
emergent S. intermedius strains have acquired some novel 
mechanism of pathogenesis resulting in increased virulence. 
Indiscriminate antibiotic use leads to selection pressure and 
subsequent development of antimicrobial resistance by various 
mechanisms like acquisition or transfer of genes. This carries 
an associated risk of plasmid-mediated transfer orgenomic co-
acquisition of virulence factors. So, antimicrobial stewardship 
might prove to be an important cornerstone in the prevention 
of emergence of new hypervirulent strains, at least to 
some extent.
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